In the last 12 months, insiders at Camp4 Therapeutics Corp ($CAMP) filed 92 transactions with the SEC: 18 open-market purchases totaling $89,954,928 and 0 sales totaling $0. Net insider sentiment: net buying.
Camp4 Therapeutics Corp operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Polaris Management Co. VII, L.L.C. (Not found) — 20 transactions totaling $21,999,979
- Enavate Sciences GP, LLC (Not found) — 3 transactions totaling $14,999,996
- 5AM Partners VI, LLC (Not found) — 7 transactions totaling $14,499,989
- Schwab Andrew J. (Director) — 8 transactions totaling $9,999,990
- Nashat Amir (Director) — 10 transactions totaling $9,999,990
View all SEC Filings for Camp4 Therapeutics Corp (CAMP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | MacLean Michael F | Director | A | Stock Option (Right to Buy) | 56000 | $0.00 | 56,000.0000 | 46,881,134 | 9999.99% | 0.12% |
| April 1, 2026 | Tardiff Daniel | Chief Scientific Officer | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 46,881,134 | 9999.99% | 0.36% |
| April 1, 2026 | Maricich Yuri | Chief Medical Officer | A | Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 46,881,134 | 9999.99% | 0.46% |
| April 1, 2026 | Gold Kelly | Chief Financial Officer | A | Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 46,881,134 | 9999.99% | 0.46% |
| April 1, 2026 | Mandel-Brehm Josh | Chief Executive Officer | A | Stock Option (Right to Buy) | 580000 | $0.00 | 580,000.0000 | 46,881,134 | 9999.99% | 1.24% |
| Dec. 11, 2025 | Gold Kelly | Chief Financial Officer | A | Stock Option (Right to Buy) | 190000 | $0.00 | 190,000.0000 | 46,881,134 | 9999.99% | 0.41% |
| Dec. 11, 2025 | Mandel-Brehm Josh | Chief Executive Officer | A | Stock Option (Right to Buy) | 425000 | $0.00 | 425,000.0000 | 46,881,134 | 9999.99% | 0.91% |
| Dec. 11, 2025 | Tardiff Daniel | Chief Scientific Officer | A | Stock Option (Right to Buy) | 145500 | $0.00 | 145,500.0000 | 46,881,134 | 9999.99% | 0.31% |
| Dec. 11, 2025 | Maricich Yuri | Chief Medical Officer | A | Stock Option (Right to Buy) | 190000 | $0.00 | 190,000.0000 | 46,881,134 | 9999.99% | 0.41% |
| Sept. 11, 2025 | Schwab Andrew J. | Not found | A | Common Stock | 2941176 | $1.53 | 5,869,091.0000 | 20,161,072 | 100.45% | 14.59% |
| Sept. 11, 2025 | 5AM Partners VI, LLC | Not found | P | Common Stock | 2941176 | $1.53 | 5,869,091.0000 | 20,161,072 | 100.45% | 14.59% |
| Sept. 11, 2025 | Polaris Management Co. VII, L.L.C. | Not found | P | Common Stock | 85468 | $1.53 | 1,106,751.0000 | 20,161,072 | 8.37% | 0.42% |
| Sept. 11, 2025 | Young Richard A | Director | P | Common Stock | 15151 | $1.65 | 170,010.0000 | 20,161,072 | 9.78% | 0.08% |
| Sept. 11, 2025 | Mandel-Brehm Josh | Chief Executive Officer | P | Common Stock | 6060 | $1.65 | 278,417.0000 | 20,161,072 | 2.23% | 0.03% |
| Sept. 11, 2025 | Gold Kelly | Chief Financial Officer | P | Common Stock | 6060 | $1.65 | 67,877.0000 | 20,161,072 | 9.80% | 0.03% |
| Sept. 11, 2025 | Maricich Yuri | Chief Medical Officer | P | Common Stock | 6060 | $1.65 | 6,060.0000 | 20,161,072 | 9999.99% | 0.03% |
| Sept. 11, 2025 | Nashat Amir | Not found | P | Common Stock | 85468 | $1.53 | 1,106,751.0000 | 20,161,072 | 8.37% | 0.42% |
| Sept. 11, 2025 | Nashat Amir | Not found | P | Common Stock | 1221721 | $1.53 | 3,734,590.0000 | 20,161,072 | 48.62% | 6.06% |
| Sept. 11, 2025 | Polaris Management Co. VII, L.L.C. | Not found | P | Common Stock | 1221721 | $1.53 | 3,734,590.0000 | 20,161,072 | 48.62% | 6.06% |
| June 25, 2025 | Boylan James P | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 25, 2025 | Thadhani Ravi I. | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 25, 2025 | Nashat Amir | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 25, 2025 | Holtzman Steven H | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 25, 2025 | Schwab Andrew J. | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 25, 2025 | Higgins Michael J | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 25, 2025 | Young Richard A | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| June 25, 2025 | Ragan Paula | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| April 1, 2025 | Mandel-Brehm Josh | Chief Executive Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 20,161,072 | 9999.99% | 0.79% |
| April 1, 2025 | Gold Kelly | Chief Financial Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 20,161,072 | 9999.99% | 0.40% |
| April 1, 2025 | Maricich Yuri | Chief Medical Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 20,161,072 | 9999.99% | 0.40% |
| April 1, 2025 | Bumcrot David | Chief Scientific Officer | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 20,161,072 | 9999.99% | 0.22% |
| March 17, 2025 | Stewart Murray | Director | A | Stock Option (Right to Buy) | 17787 | $0.00 | 17,787.0000 | 20,161,072 | 9999.99% | 0.09% |
| March 17, 2025 | WILLIAMS DOUGLAS E | Director | A | Stock Option (Right to Buy) | 17787 | $0.00 | 17,787.0000 | 20,161,072 | 9999.99% | 0.09% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 1250061 | $0.00 | 1,250,061.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 87448 | $0.00 | 87,448.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 353718 | $0.00 | 1,603,779.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 24745 | $0.00 | 112,193.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | P | Common Stock | 909090 | $11.00 | 909,090.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series A Prime Preferred Stock | 14020475 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series A Prime Preferred Stock | 980829 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series B Preferred Stock | 3967234 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series B Preferred Stock | 277536 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | AH Equity Partners Bio I, L.L.C. | Not found | C | Series A Prime Preferred Stock | 15001312 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | AH Equity Partners Bio I, L.L.C. | Not found | P | Common Stock | 545454 | $11.00 | 2,125,339.0000 | 0 | 34.52% | 0.00% |
| Oct. 15, 2024 | AH Equity Partners Bio I, L.L.C. | Not found | P | Common Stock | 181818 | $11.00 | 2,125,339.0000 | 0 | 9.36% | 0.00% |
| Oct. 15, 2024 | AH Equity Partners Bio I, L.L.C. | Not found | C | Common Stock | 1398067 | $0.00 | 1,943,521.0000 | 0 | 256.31% | 0.00% |
| Oct. 15, 2024 | Enavate Sciences GP, LLC | Not found | C | Series B Preferred Stock | 27166530 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Enavate Sciences GP, LLC | Not found | P | Common Stock | 1363636 | $11.00 | 3,785,802.0000 | 0 | 56.30% | 0.00% |
| Oct. 15, 2024 | Enavate Sciences GP, LLC | Not found | C | Common Stock | 2422166 | $0.00 | 2,422,166.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Northpond Ventures II GP, LLC | Not found | C | Series B Preferred Stock | 5287303 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Northpond Ventures II GP, LLC | Not found | C | Series A Prime Preferred Stock | 11251624 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Northpond Ventures II GP, LLC | Not found | P | Common Stock | 763636 | $11.00 | 2,238,244.0000 | 0 | 51.79% | 0.00% |
| Oct. 15, 2024 | Northpond Ventures II GP, LLC | Not found | C | Common Stock | 471415 | $0.00 | 2,238,244.0000 | 0 | 26.68% | 0.00% |
| Oct. 15, 2024 | Northpond Ventures II GP, LLC | Not found | C | Common Stock | 1003193 | $0.00 | 2,238,244.0000 | 0 | 81.23% | 0.00% |
| Oct. 15, 2024 | AH Equity Partners Bio I, L.L.C. | Not found | C | Series B Preferred Stock | 679163 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Common Stock | 1250061 | $0.00 | 1,250,061.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | 5AM Partners VI, LLC | Not found | C | Series B Preferred Stock | 3395816 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | 5AM Partners VI, LLC | Not found | C | Series B Preferred Stock | 4244770 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | 5AM Partners VI, LLC | Not found | C | Series A Prime Preferred Stock | 15002166 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | 5AM Partners VI, LLC | Not found | P | Common Stock | 909090 | $11.00 | 2,927,915.0000 | 0 | 45.03% | 0.00% |
| Oct. 15, 2024 | 5AM Partners VI, LLC | Not found | C | Common Stock | 302770 | $0.00 | 2,927,915.0000 | 0 | 11.53% | 0.00% |
| Oct. 15, 2024 | 5AM Partners VI, LLC | Not found | C | Common Stock | 1716055 | $0.00 | 2,018,825.0000 | 0 | 566.79% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series A Prime Preferred Stock | 980829 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series B Preferred Stock | 3967234 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series B Preferred Stock | 277536 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 1250061 | $0.00 | 1,250,061.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 87448 | $0.00 | 87,448.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 353718 | $0.00 | 1,603,779.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Common Stock | 24745 | $0.00 | 112,193.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | P | Common Stock | 909090 | $11.00 | 909,090.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Polaris Management Co. VII, L.L.C. | Not found | C | Series A Prime Preferred Stock | 14020475 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Common Stock | 87448 | $0.00 | 87,448.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Common Stock | 353718 | $0.00 | 1,603,779.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Common Stock | 24745 | $0.00 | 112,193.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | P | Common Stock | 909090 | $11.00 | 909,090.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Series A Prime Preferred Stock | 14020475 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Series A Prime Preferred Stock | 980829 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Series B Preferred Stock | 3967234 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Schwab Andrew J. | Director | C | Common Stock | 1337592 | $0.00 | 1,337,592.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Nashat Amir | Director | C | Series B Preferred Stock | 277536 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Schwab Andrew J. | Director | C | Common Stock | 378463 | $0.00 | 1,716,055.0000 | 0 | 28.29% | 0.00% |
| Oct. 15, 2024 | Schwab Andrew J. | Director | C | Common Stock | 302770 | $0.00 | 302,770.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Schwab Andrew J. | Director | P | Common Stock | 909090 | $11.00 | 2,625,145.0000 | 0 | 52.98% | 0.00% |
| Oct. 15, 2024 | Schwab Andrew J. | Director | C | Series A Prime Preferred Stock | 15002166 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Schwab Andrew J. | Director | C | Series B Preferred Stock | 4244770 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Schwab Andrew J. | Director | C | Series B Preferred Stock | 3395816 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Holtzman Steven H | Director | C | Common Stock | 8917 | $0.00 | 108,946.0000 | 0 | 8.91% | 0.00% |
| Oct. 15, 2024 | Holtzman Steven H | Director | C | Series A Prime Preferred Stock | 100014 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Young Richard A | Director | C | Common Stock | 8917 | $0.00 | 154,859.0000 | 0 | 6.11% | 0.00% |
| Oct. 15, 2024 | Young Richard A | Director | C | Series A Prime Preferred Stock | 100014 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Mandel-Brehm Josh | Chief Executive Officer | C | Common Stock | 605 | $0.00 | 272,357.0000 | 0 | 0.22% | 0.00% |
| Oct. 15, 2024 | Mandel-Brehm Josh | Chief Executive Officer | C | Series B Preferred Stock | 6791 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |